Remco Munnik

Founder and Owner
Aracana Life Sciences

Articles by Remco Munnik

Munnik Revisits His 2026 Predictions: A Midyear Check-In on Regulatory Reform, Data, and AI in Pharma

July 13th 2026

Arcana Life Sciences' Remco Munnik revisits his 2026 predictions on EU regulatory reform, AI adoption, and data governance, and previews pharma's biggest challenges for H2 2026.

Latest Updated Articles

Remco Munnik

Articles by Remco Munnik

Munnik Revisits His 2026 Predictions: A Midyear Check-In on Regulatory Reform, Data, and AI in Pharma

Latest Updated Articles

Trending on Pharmaceutical Technology

The FDA Moves to Modernize Drug Manufacturing Registration

What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline

Regulatory Actions Impacting Biologics

Structuring Tech Transfer for Optimized Collaboration

It’s Time to Build a More Scalable, Connected CRO